White matter lesions in Fabry disease before and after enzyme replacement therapy: a 2-year follow-up.
about
Enzyme replacement therapy for Anderson-Fabry diseaseEnzyme replacement therapy for Anderson-Fabry diseaseEnzyme replacement therapy for Anderson-Fabry diseaseRecommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document.The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense MutationsEffects of enzyme replacement therapy in Fabry disease--a comprehensive review of the medical literature.Cell microencapsulation: a potential tool for the treatment of neuronopathic lysosomal storage diseases.Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis: effectiveness of ERT in different disease stages.Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factorsDouble-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations.Kidney function and 24-hour proteinuria in patients with Fabry disease during 36 months of agalsidase alfa enzyme replacement therapy: a Brazilian experience.Enzyme replacement in Fabry disease: pharmacokinetics and pharmacodynamics of agalsidase alpha in children and adolescents.Enzyme replacement therapy and white matter hyperintensity progression in Fabry disease
P2860
Q24200877-99799BC7-DEF4-42E0-A334-AC4216D00AB0Q24235483-C950CF15-BEE7-4053-BC7A-5A2FF2459060Q26471010-4A8F9806-1DE8-4862-9035-8D7ADBA6FE35Q35247511-BFB13E50-EDFF-489C-B90D-15E2CA96CED2Q36213022-38D1AD00-2440-491D-BD48-B39DA7CD30DEQ37801828-7D96C285-DE3B-4ACC-8AC9-3E17EFD03478Q37879987-102319DE-9E2D-42B4-B5F6-2B10CC3BBB3CQ38184922-AAEE59E5-2EDD-45E5-B446-DF65B29D278FQ41200738-E6E792F8-55E1-4455-9CEE-C1BE1DF383C2Q41671504-26462FBA-2139-487C-AD2D-BC4A52A05969Q51602611-FBF197E9-B83E-4B99-84BA-56B55FA13B4AQ51741934-DE0B9438-AFF3-4558-8C92-891E0F7CD21DQ57291693-FBDCD31B-7689-4345-A1D3-A551D151F7A9
P2860
White matter lesions in Fabry disease before and after enzyme replacement therapy: a 2-year follow-up.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
White matter lesions in Fabry ...... t therapy: a 2-year follow-up.
@en
White matter lesions in Fabry ...... t therapy: a 2-year follow-up.
@nl
type
label
White matter lesions in Fabry ...... t therapy: a 2-year follow-up.
@en
White matter lesions in Fabry ...... t therapy: a 2-year follow-up.
@nl
prefLabel
White matter lesions in Fabry ...... t therapy: a 2-year follow-up.
@en
White matter lesions in Fabry ...... t therapy: a 2-year follow-up.
@nl
P2093
P2860
P1476
White matter lesions in Fabry ...... t therapy: a 2-year follow-up.
@en
P2093
Cláudia Cecchin
Cláudio Pitta-Pinheiro
Cristina B O Netto
Fernanda Pereira
Flávio Aesse
João Marconato
Laura B Jardim
Leonardo M Vedolin
Luciane Kalakun
Maira G Burin
P2860
P304
P356
10.1590/S0004-282X2006000500002
P577
2006-09-01T00:00:00Z